COX-2 and iNOS are critical in advanced glycation end product-activated chondrocytes in vitro

European Journal of Clinical Investigation

Volumn 39, Issue 5, 2009, Pages 417-428

  Huang, C Y ^a   Hung, L F ^a   Liang, C C T ^a   Ho, L J ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Chondrocytes; Cyclooxygenase 2; Inducible nitric oxide synthase; Osteoarthritis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; ARACHIDONIC ACID; CYCLOOXYGENASE 2; GLYCOSAMINOGLYCAN POLYSULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; METHYLGLYOXAL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PHOSPHOTRANSFERASE; PROSTAGLANDIN E2; PROTEIN KINASE; PROTEOGLYCAN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE INJURY; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; STAINING; SWINE; WESTERN BLOTTING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; CELLS, CULTURED; CHONDROCYTES; CYCLOOXYGENASE 2; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OSTEOARTHRITIS; SWINE; YOUNG ADULT;

EID: 63849158704     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02106.x     Document Type: Article

References (39)

1. Holt I, Cooper RG, Hopkins SJ. Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. Eur J Clin Invest 1991 21 : 479 84.
2. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007 213 : 626 34.
3. Verzijl N, Bank RA, TeKoppele JM, DeGroot J. AGEing and osteoarthritis: a different perspective. Curr Opin Rheumatol 2003 15 : 616 22.
4. Loeser RF, Yammani RR, Carlson CS, Chen H, Cole A, Im HJ et al. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. Arthritis Rheum 2005 52 : 2376 85.
5. DeGroot J, Verzijl N, Wenting-van Wijk MJ, Jacobs KM, Van El B, Van Roermund PM et al. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum 2004 50 : 1207 15.
6. DeGroot J, Verzijl N, Bank RA, Lafeber FP, Bijlsma JW, TeKoppele JM. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum 1999 42 : 1003 9.
7. Verzijl N, DeGroot J, Ben ZC, Brau-Benjamin O, Maroudas A, Bank RA et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 2002 46 : 114 23.
8. Yammani RR, Carlson CS, Bresnick AR, Loeser RF. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum 2006 54 : 2901 11.
9. Amin AR, Attur M, Abramson SB. Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr Opin Rheumatol 1999 11 : 202 9.
10. Abramson SB, Attur M, Amin AR, Clancy R. Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 2001 3 : 535 41.
11. Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 1998 41 : 1266 74.
12. Chen Q, Liu SQ, Du YM, Peng H, Sun LP. Carboxymethyl-chitosan protects rabbit chondrocytes from interleukin-1beta-induced apoptosis. Eur J Pharmacol 2006 541 : 1 8.
13. Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995 206 : 15 21.
14. Pelletier JP, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998 41 : 1275 86.
15. Pelletier JP, Jovanovic DV, Lascau-Coman V, Fernandes JC, Manning PT, Connor JR et al. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum 2000 43 : 1290 9.
16. Pelletier JP, Fernandes JC, Jovanovic DV, Reboul P, Martel-Pelletier J. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase. J Rheumatol 2001 28 : 2509 19.
17. Akimoto H, Yamazaki R, Hashimoto S, Sato T, Ito A. 4-Hydroxy aceclofenac suppresses the interleukin-1-induced production of promatrix metalloproteinases and release of sulfated-glycosaminoglycans from rabbit articular chondrocytes. Eur J Pharmacol 2000 401 : 429 36.
18. Young AA, Smith MM, Smith SM, Cake MA, Ghosh P, Read RA et al. Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis. Arthritis Res Ther 2005 7 : R852 61.
19. Kim HA, Cho ML, Choi HY, Yoon CS, Jhun JY, Oh HJ et al. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum 2006 54 : 2152 63.
20. Shanmugam N, Kim YS, Lanting L, Natarajan R. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J Biol Chem 2003 278 : 34834 44.
21. Wu JT, Tu MC, Zhung P. Advanced glycation end product (AGE): characterization of the products from the reaction between D-glucose and serum albumin. J Clin Lab Anal 1996 10 : 21 34.
22. Ho LJ, Lin LC, Hung LF, Wang SJ, Lee CH, Chang DM et al. Retinoic acid blocks pro-inflammatory cytokine-induced matrix metalloproteinase production by down-regulating JNK-AP-1 signaling in human chondrocytes. Biochem Pharmacol 2005 70 : 200 8.
23. Saito S, Katoh M, Masumoto M, Matsumoto S, Masuho Y. Collagen degradation induced by the combination of IL-1alpha and plasminogen in rabbit articular cartilage explant culture. J Biochem 1997 122 : 49 54.
24. Lee MS, Ikenoue T, Trindade MC, Wong N, Goodman SB, Schurman DJ et al. Protective effects of intermittent hydrostatic pressure on osteoarthritic chondrocytes activated by bacterial endotoxin in vitro. J Orthop Res 2003 21 : 117 22.
25. Bradbury DA, Corbett L, Knox AJ. PI 3-kinase and MAP kinase regulate bradykinin induced prostaglandin E(2) release in human pulmonary artery by modulating COX-2 activity. FEBS Lett 2004 560 : 30 4.
26. Cheng SM, Yang SP, Ho LJ, Tsao TP, Juan TY, Chang DM et al. Down-regulation of c-jun N-terminal kinase-activator protein-1 signaling pathway by Ginkgo biloba extract in human peripheral blood T cells. Biochem Pharmacol 2003 66 : 679 89.
27. Enobakhare BO, Bader DL, Lee DA. Quantification of sulfated glycosaminoglycans in chondrocyte/alginate cultures, by use of 1,9-dimethylmethylene blue. Anal Biochem 1996 243 : 189 91.
28. Rosenberg L. Chemical basis for the histological use of safranin O in the study of articular cartilage. J Bone Joint Surg Am 1971 53 : 69 82.
29. Verzijl N, DeGroot J, Oldehinkel E, Bank RA, Thorpe SR, Baynes JW et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 2000 350 (Pt 2 381 7.
30. Handl M, Filova E, Kubala M, Lansky Z, Kolacna L, Vorlicek J et al. Fluorescent advanced glycation end products in the detection of factual stages of cartilage degeneration. Physiol Res 2007 56 : 235 42.
31. Ohgami N, Nagai R, Miyazaki A, Ikemoto M, Arai H, Horiuchi S et al. Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products. J Biol Chem 2001 276 : 13348 55.
32. Allport VC, Slater DM, Newton R, Bennett PR. NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod 2000 6 : 561 5.
33. Cho MK, Suh SH, Kim SG. JunB/AP-1 and NF-kappa B-mediated induction of nitric oxide synthase by bovine type I collagen in serum-stimulated murine macrophages. Nitric Oxide 2002 6 : 319 32.
34. Thomas B, Thirion S, Humbert L, Tan L, Goldring MB, Bereziat G et al. Differentiation regulates interleukin-1beta-induced cyclo-oxygenase-2 in human articular chondrocytes: role of p38 mitogen-activated protein kinase. Biochem J 2002 362 : 367 73.
35. Martel-Pelletier J, Mineau F, Jovanovic D, Di Battista JA, Pelletier JP. Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated protein kinase (MAPKAPK). Arthritis Rheum 1999 42 : 2399 409.
36. Nah SS, Choi IY, Lee CK, Oh JS, Kim YG, Moon HB et al. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes. Rheumatology (Oxford, England) 2008 47 : 425 31.
37. Senolt L, Braun M, Olejarova M, Forejtova S, Gatterova J, Pavelka K. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein. Ann Rheum Dis 2005 64 : 886 90.
38. DeGroot J. The AGE of the matrix: chemistry, consequence and cure. Curr Opin Pharmacol 2004 4 : 301 5.
39. Steenvoorden MM, Huizinga TW, Verzijl N, Bank RA, Ronday HK, Luning HA et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum 2006 54 : 253 63.